Management of Multiple Skin Abscesses in Former IV Drug Users
For multiple skin abscesses in a former IV drug user, perform incision and drainage as the primary treatment, add empirical antibiotics covering MRSA (TMP-SMX, doxycycline, or clindamycin for 5-10 days), culture all abscesses, and consider decolonization measures if recurrences continue despite optimal wound care.
Primary Treatment: Incision and Drainage
The cornerstone of abscess management is incision and drainage (I&D), regardless of drug use history 1, 2. However, the presence of multiple abscesses automatically triggers the need for adjunctive antibiotic therapy, as this represents "severe or extensive disease involving multiple sites of infection" 2.
Empirical Antibiotic Coverage
Given this patient's IV drug use history, empirical coverage must target MRSA, which is highly prevalent in this population 1. First-line oral options include:
- TMP-SMX 1-2 double-strength tablets twice daily 2
- Doxycycline 100 mg twice daily 2
- Clindamycin 300-450 mg three times daily 2
Duration should be 5-10 days based on clinical response 1, 2.
Critical Caveat for Drug Users
The IDSA guidelines specifically state that injection drug use is an indication for coverage against both MRSA and streptococci 1. If you choose TMP-SMX or doxycycline (which have uncertain streptococcal activity), add amoxicillin 500 mg three times daily 2. Alternatively, use clindamycin alone or linezolid alone, as both cover streptococci 2.
Culture Every Abscess
Obtain cultures from all abscesses before drainage 1. This is non-negotiable in patients with multiple lesions, as it guides subsequent therapy and identifies polymicrobial infections (common in drug users, with anaerobes present in >50% of cases) 3, 4.
Special Considerations for Former Drug Users
Check for Complications
- Rule out foreign bodies (broken needles) with radiography 5
- Perform duplex ultrasound to exclude vascular complications or pseudoaneurysms 5
- Assess for systemic infection: If fever is present, hospitalize and evaluate for endocarditis 5, 6
- Examine for deep extension: Multiple abscesses raise concern for necrotizing fasciitis or myositis 3, 7
Tetanus Prophylaxis
The incidence of tetanus is significantly elevated in drug users compared to the general population. Administer tetanus booster if vaccination status is unclear 5.
Hospitalization Criteria
Admit if the patient has:
- Fever or systemic signs of infection 1, 5
- Rapidly progressive infection 2
- Abscesses in difficult-to-drain locations (face, hand, genitalia) 2
- Signs of deeper infection or necrotizing process 1
Managing Recurrent Abscesses
Since this patient has multiple abscesses, recurrence risk is substantial. After acute treatment:
Search for local causes: pilonidal cyst, hidradenitis suppurativa, foreign material 1
Consider decolonization if recurrences persist despite optimal wound care 1, 2:
Educate on wound care 2:
- Keep wounds covered with clean, dry bandages
- Hand hygiene with soap/water or alcohol-based sanitizer
- Clean high-touch surfaces
Common Pitfalls to Avoid
- Do not use rifampin as monotherapy or adjunctive therapy for skin abscesses 2
- Do not assume simple cellulitis when purulent drainage is present—this requires MRSA coverage 2
- Do not skip cultures in patients with multiple lesions or drug use history 1
- Do not discharge febrile patients without ruling out endocarditis 5
- Do not forget anaerobic coverage if hospitalization is required—use vancomycin plus piperacillin-tazobactam or a carbapenem 1
If Hospitalization Required
For severe cases requiring admission, use IV therapy 2:
- Vancomycin (first-line)
- Linezolid 600 mg IV/PO twice daily
- Daptomycin 4 mg/kg IV once daily
Add broad-spectrum coverage (piperacillin-tazobactam or carbapenem) if severely compromised or concern for polymicrobial/anaerobic infection 1.